Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
58,837,653
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
10,061
-
Shares change
-
-693
-
Total reported value, excl. options
-
$102,522
-
Value change
-
-$7,062
-
Number of sells
-
-1
-
Price
-
$10.19
Significant Holders of Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) as of Q4 2023
1 filings reported holding CGEM - Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,061 shares
of 58,837,653 outstanding shares and own 0.02% of the company stock.
Largest 10 shareholders include MPM BioImpact LLC (7,648,268 shares), Blue Owl Capital Holdings LP (3,419,842 shares), FRANKLIN RESOURCES INC (3,281,280 shares), BVF INC/IL (3,196,701 shares), BlackRock Inc. (2,462,274 shares), VANGUARD GROUP INC (1,771,443 shares), BRAIDWELL LP (1,240,865 shares), AMERICAN INTERNATIONAL GROUP, INC. (1,236,564 shares), Nextech Invest Ltd. (1,221,145 shares), and CITADEL ADVISORS LLC (1,132,889 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.